Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,488 | 22,212 | 26,230 | 27,382 | 30,137 |
| Inventories | 55 | 51 | 61 | 57 | 71 |
| TOTAL | $18,645 | $24,955 | $28,555 | $29,420 | $32,615 |
| Non-Current Assets | |||||
| PPE Net | 1,385 | 1,348 | 1,291 | 1,218 | 1,029 |
| Intangibles | 18,084 | 18,620 | 20,076 | 21,645 | 21,850 |
| Other Non-Current Assets | 864 | 907 | 953 | 1,175 | 1,396 |
| TOTAL | $20,333 | $20,874 | $22,321 | $24,038 | $24,275 |
| Total Assets | $38,978 | $45,830 | $50,876 | $53,458 | $56,890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,502 | 2,681 | 2,251 | 2,779 | 2,244 |
| TOTAL | $1,966 | $3,147 | $2,722 | $3,287 | $2,727 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 463 | 466 | 471 | 508 | 483 |
| Other Non-Current Liabilities | 1,516 | 383 | 772 | 1,020 | 900 |
| TOTAL | $1,181 | $1,225 | $1,237 | $1,301 | $1,358 |
| Total Liabilities | $3,147 | $4,372 | $3,959 | $4,588 | $4,085 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,342 | 50,322 | 50,248 | 48,869 | 48,799 |
| Common Shares | 115,548 | 115,145 | 114,740 | 108,348 | 107,852 |
| Retained earnings | -85,433 | -80,470 | -75,109 | -71,597 | -67,317 |
| Other shareholders' equity | 11,623 | 12,689 | 13,192 | 12,024 | 12,176 |
| TOTAL | $35,831 | $41,458 | $46,917 | $48,870 | $52,805 |
| Total Liabilities And Equity | $38,978 | $45,830 | $50,876 | $53,458 | $56,890 |